India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Investment will fund expansion to meet rising demand for CRDMO services
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Executes the first project for developing and manufacturing a novel anticancer mAb
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
Subscribe To Our Newsletter & Stay Updated